Back to INBX
UBS Group AG INBX Position History
Inhibrx Biosciences, Inc. • Healthcare
Quarters held
8
Latest value
$42K
Q3 2026
Peak value
$5.8M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $290K |
| Q3 2025 | $27K |
| Q4 2025 | $5.8M |
| Q4 2025 | $9K |
| Q1 2026 | $3.2M |
| Q2 2026 | $3.3M |
| Q3 2026 | $3.4M |
| Q3 2026 | $42K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $42K | 415 | — | — |
| Q3 2026 | $3.4M | 33.6K | — | — |
| Q2 2026 | $3.3M | 35.0K | — | — |
| Q1 2026 | $3.2M | 48.1K | — | — |
| Q4 2025 | $9K | 113 | — | — |
| Q4 2025 | $5.8M | 73.6K | — | — |
| Q3 2025 | $27K | 804 | — | — |
| Q3 2025 | $290K | 8.6K | — | — |
Other funds holding INBX
$271.7M
$172.4M
$131.2M
$129.3M
$126.4M
$125.3M